Bandari
Mohan Bandari, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20090259051 | CARVEDILOL PHOSPHATE SESQUIHYDRATE - The present invention relates a novel crystalline 1-(Carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy) ethyl]amino]-2-propanol phosphate sesquihydrate (Carvedilol dihydrogenphosphate sesquihydrate), methods of preparing the sesquihydrate by adding phosphoric acid to a suspension of Carvedilol in water, water miscible solvents or a mixture of water and water miscible organic solvent followed by isolating the product directly or by adding solvent. | 10-15-2009 |
20110034701 | ONE POT PROCESS FOR THE PREPARATION OF CANDESARTAN - Present invention is to provide one pot synthesis of candesartan without isolating the ester intermediate. | 02-10-2011 |
20110092708 | PROCESS FOR THE PREPARATION OF MONTELUKAST AND ITS SALTS THEREOF - The present invention relates to the alkyl amine salts of Montelukast and methods for their preparation and conversion of Montelukast amine salts to Montelukast or Montelukast alkali/alkaline salt. | 04-21-2011 |
Mohan Bandari, Secunderabad IN
Patent application number | Description | Published |
---|---|---|
20090018344 | PROCESS FOR THE PREPARATION OF CANDESARTAN CILEXETIL - The invention relates to process for the preparation of Candesartan cilexetil. More particularly, it relates to the preparation of pure candesartan cilexetil by the deprotection of Trityl candesartan cilexetil with inorganic acids. | 01-15-2009 |
20090062550 | Process for the Large Scale Production of Rizatriptan Benzoate - The present invention provides a method for preparing pure Rizatriptan benzoate having purity more than 99.5% and dimer impurity less than 0.1% comprises, i) Condensation of 1,2,4-Triazole with 4-Nitro benzyl bromide to yield 1-(4-nitrophenyl)methyl-1,2,4-triazole ii) Reducing the 1-(4-nitrophenyl)methyl-1,2,4-triazole to give 1-(4-aminophenyl)methyl-1,2,4-triazole iii) Converting 1-(4-aminophenyl)methyl-1,2,4-triazole to 1-(4-hydrazinophenyl)methyl-1,2,4-triazole hydrochloride iv) Condensing the hydrazine derivative with 4-(Dimethylamino) butanal diethylacetal to get Rizatriptan and v) Salification of Rizatriptan to Rizatriptan benzoate. | 03-05-2009 |
20090240064 | CRYSTALLINE FORM OF ATORVASTATIN HEMI-CALCIUM - The present invention relates to a new crystalline form of Atorvastatin hemi-calcium and also relates to a process for preparation of the same by treating Atorvastatin hemi-calcium amorphous form or form-I or mixture of amorphous and crystalline forms with methanol. | 09-24-2009 |
Roja Bandari, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20140040277 | PREDICTING SHARING ON A SOCIAL NETWORK - A non-transitory computer-readable storage device includes instructions that, when executed, cause one or more processors to calculate a score for an article, from a source, using the average number of times other articles belonging to the source were shared on a social network (“t-density”). The processor are further caused to predict, using the score, a number of times the article will be shared on the social network. | 02-06-2014 |
Sreedhar Bandari, Karimnagar IN
Patent application number | Description | Published |
---|---|---|
20100048607 | FORMULATIONS COMPRISING PALONOSETRON - Pharmaceutical compositions comprising palonosetron and its pharmaceutically acceptable salts, in the form of a ready-to-use solution or a lyophilized form. Specific embodiments of the invention relate to stable pharmaceutical formulations of palonosetron and its pharmaceutically acceptable salts, wherein the formulation does not comprise a chelating agent or an antioxidant. | 02-25-2010 |
20120238596 | FORMULATIONS COMPRISING PALONOSETRON - Pharmaceutical compositions comprising palonosetron and its pharmaceutically acceptable salts, in the form of a ready-to-use solution or a lyophilized form. Specific embodiments of the invention relate to stable pharmaceutical formulations of palonosetron and its pharmaceutically acceptable salts, wherein the formulation does not comprise a chelating agent or an antioxidant. | 09-20-2012 |
Sreenath Bandari, Santa Clara, CA US
Patent application number | Description | Published |
---|---|---|
20150324238 | LOAD DISTRIBUTION OF LOGICAL SWITCH ROUTERS IN A DISTRIBUTED SYSTEM - A tool for supporting load distribution across one or more logical switch routers in a distributed system. The tool includes a first software module configurable to launch and monitor one or more application processes within the one or more logical switch routers in the distributed system. The tool includes a second software module configurable to manage a plurality of system information for the one or more logical switch routers in the distributed system. The tool includes a third software module configurable to control and manage a plurality of system resources in the distributed system. The tool includes a fourth software module configurable to control and manage a plurality of physical ports and a plurality of virtual ports in the distributed system. The tool includes a fifth software module configurable to manage a plurality of load distribution policies for the one or more logical switch routers in the distributed system. | 11-12-2015 |